Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$261,438,609
+$23,240,953 QoQ
Shares Held
1,038,939
-5.1% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#129
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mitsubishi UFJ Trust & Banking Corp holds $1,884,441,265 across 11 Drug Manufacturers - General names. ABBV ranks #3 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
448,840 | $538,352,205 | |
| 2 | JNJ |
Johnson & Johnson
|
1,684,383 | $427,782,750 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
1,038,939 | $261,438,609 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,727,562 | $221,991,717 | |
| 5 | AMGN |
Amgen Inc
|
304,371 | $110,218,826 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,862,476 | $107,315,867 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
813,745 | $102,808,542 | |
| 8 | PFE |
Pfizer Inc
|
3,137,191 | $75,543,558 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $261,438,609 | 1,038,939 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $238,197,656 | 1,095,212 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $249,547,866 | 1,092,161 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $260,345,890 | 1,124,410 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $212,069,178 | 1,142,491 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $247,704,600 | 1,182,248 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $255,022,600 | 1,435,130 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $285,954,396 | 1,448,017 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $263,996,551 | 1,539,159 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $285,464,875 | 1,567,627 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $249,921,513 | 1,612,709 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $231,400,444 | 1,552,398 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $225,298,064 | 1,672,219 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $263,029,028 | 1,650,430 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $270,235,513 | 1,672,146 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $210,422,489 | 1,567,860 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $237,531,861 | 1,550,874 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $230,349,554 | 1,420,946 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $200,029,397 | 1,477,322 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $161,454,745 | 1,496,753 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $177,416,897 | 1,575,079 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $201,192,666 | 1,859,108 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $215,945,072 | 2,015,353 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $164,199,278 | 1,874,635 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $172,321,411 | 1,755,158 | Shares | Sole | 2020-09-11 | |
| 2020-03-31 | $123,027,724 | 1,614,749 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||